KAITLYN PIZZINI: Open Payments
NPI 1508255993 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 80 payments from 12 companies in 2025. Trend: 2023 $1,999 · 2024 $1,026 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 53 | $673 |
| Medtronic, Inc. | 12 | $198 |
| ABBVIE INC. | 5 | $119 |
| IMMUNITYBIO, INC. | 2 | $62 |
| Dendreon Pharmaceuticals LLC | 1 | $53 |
| BLUEWIND MEDICAL | 1 | $46 |
| Teleflex LLC | 1 | $29 |
| UROGEN PHARMA, INC. | 1 | $26 |
| ACCORD HEALTHCARE, INC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: GEMTESA, INTERSTIM, BOTOX, ORGOVYX, ANKTIVA, PROVENGE, REVI, UROLIFT.
Industry payments across TX — which companies pay providers there.
